- 3 - afflicted with sickle cell anemia. Petitioner developed what he referred to as a "compound" that he administered to his daughter and that, to petitioner's satisfaction, placed her sickle cell anemia in remission. Petitioner was convinced that his compound was effective because, for a time period in which he was unable to administer the compound to his daughter, her condition worsened, and she lost her left eye. When the compound was again administered to her, she became well. Petitioner is not a doctor of medicine, although he holds a college degree in biology, chemistry, and physics. For the years prior to the years in question, petitioner did not consider his home laboratory as a trade or business for tax purposes. Also, the record does not indicate that petitioner ever contacted or made known to doctors and/or pharmaceutical companies his development of the compound, which he was satisfied relieved his daughter of her sickle cell anemia. Petitioner did not administer this compound to anyone other than his daughter, nor did he ever sell or market the compound. He was of the belief that his compound would be effective in suppressing AIDS and other human immune system problems. Sometime in 1991, or a short time prior thereto, petitioner decided to proceed commercially with his compound. He discontinued his contracting business and spent considerable amounts of money in improving his laboratory. He adopted a tradePage: Previous 1 2 3 4 5 6 7 8 Next
Last modified: May 25, 2011